Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history
Tirzepatide monthly cost paths (2026, self-pay unless noted) Path Compounded via telehealth (503A) Typical monthly cost Notes Path LillyDirect self-pay Zepbound vials Typical monthly cost Notes Path Retail brand (Zepbound / Mounjaro) Typical monthly cost Notes Path Lilly savings card Typical monthly cost Notes Prices change often confirm current pricing directly with the provider or pharmacy
Reliable wholesale distribution support
Saxena, V
US$ 29.61
US$ 29.20
US$ 29.02
US$ 27.92
